|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Depreciation | |||||
| Amortization of premiums on available-for-sale securities, net | |||||
| Capitalized additions to servicing rights | |||||
| Servicing rights amortization and impairment | |||||
| Amortization of core deposit intangible | |||||
| Amortization of customer list intangible | |||||
| Net accretion of fair value adjustments | |||||
| Amortization of subordinated note issuance costs | |||||
| Stock-based compensation expense | |||||
| Director stock awards | |||||
| Deferred income taxes | |||||
| Provision for credit losses-Off balance sheet credit exposures | |||||
| Provision for credit losses - loans | |||||
| Provision for (recovery of) credit losses - off balance sheet credit exposures | |||||
| Gain on sale of loans held for sale | |||||
| Originations of loans held for sale | |||||
| Proceeds from sale of loans held for sale | |||||
| Gain on derivatives | |||||
| Loss (gain) on sale of other assets owned | |||||
| Loss on sales of available-for-sale securities | |||||
| Increase in cash surrender value of bank owned life insurance | |||||
| Change in other assets and other liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Activity in available-for-sale securities: | |||||
| Maturities, prepayments and calls | |||||
| Sales | |||||
| Purchases | |||||
| Activity in other securities, at cost: | |||||
| Purchases | |||||
| Purchases of FHLB stock | |||||
| Proceeds from redemption of FHLB stock | |||||
| Purchase of bank owned life insurance | |||||
| Proceeds from bank owned life insurance | |||||
| Change in interest-bearing time deposits | |||||
| Proceeds from sale of other assets owned | |||||
| Additions to premises and equipment | |||||
| Net (increase) decrease on loan originations and principal collections | |||||
| Acquisition, net of cash received | |||||
| Peoples Federal Savings and Loan | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Net change in deposits | |||||
| Net change in federal funds purchased and securities sold under agreements to repurchase | |||||
| Proceeds of FHLB advances | |||||
| Repayment of FHLB advances | |||||
| Proceeds (Repayment) of other borrowings | |||||
| Purchase of treasury stock | |||||
| Cash dividends paid on common stock | |||||
| Net cash used in financing activities | |||||
| Net (Decrease) Increase in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents - Beginning of Year | |||||
| Cash and Cash Equivalents - End of Year | |||||
| Supplemental Information | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Federal income taxes paid | |||||
| State income taxes paid | |||||
| Total income taxes paid | |||||
| Supplemental noncash disclosures: | |||||
| Transfer of loans to other real estate owned | |||||
| Cash dividends declared not paid | |||||
| Fair value of assets acquired | |||||
| Peoples Federal Savings and Loan | |||||
| Less: common stock issued | |||||
| Treasury stock repurchased | |||||
| Peoples Federal Savings and Loan | |||||
| Total treasury stock repurchased | |||||
| Liabilities assumed | |||||
| Peoples Federal Savings and Loan | |||||
Loading...